Table 2.
Individual characteristics | General practice characteristics | |||||
Participant no. | Gender | Employer and work location | Years since registration | Years since qualifying as independent prescriber | Practice list size | Indices of multiple deprivation decile* |
General practitioners | ||||||
P10 | F | Practice, England (West) | 20 | 5000–≤10 000 | ≤5 | |
P12 | M | Practice, England (South West) | 36 | 5000–≤10 000 | >5 | |
P13 | F | Practice, Scotland | 26 | 5000–≤10 000 | >5† | |
P14 | F | Practice, England (South West) | 31 | 5000–≤10 000 | >5 | |
P16 | F | Practice, England (South West) | 26 | >10 000 | >5 | |
P18 | F | Practice, England (Midlands) | 12 | 5000–≤10 000 | ≤5 | |
Practice-based pharmacists | ||||||
P3 | M | Practice, England (South) | >10 | >5 | >10 000 | >5 |
P9 | M | Group of four practices, England (London) | <10 | ≤5 | <5000 | ≤5 |
>10 000 | >5 | |||||
>10 000 | <5 | |||||
>10 000 | <5 | |||||
P11 | M | Practice, England (West) | <10 | ≤5 | >10 000 | >5 |
P22 | M | Practice, England (South) | >10 | ≤5 | >10 000 | ≤5 |
P29 | F | Practice, England (East) | <10 | ≤5 | >10 000 | >5 |
P32 | M | Community pharmacy/practice, England (South) | >10 | ≤5 | 5000–≤10 000 | >5 |
Nurses | ||||||
P5 | F | Practice, Wales | >10 | >5 | >10 000 | >5† |
P1 | M | Practice, England (West) | >10 | >5 | >10 000 | >5 |
P15 | F | Practice, England (West) | >10 | >5 | >10 000 | >5 |
P19 | F | Practice, England (Midlands) | >10 | >5 | >10 000 | ≤5 |
P21 | F | Practice, England (South) | >10 | ≤5 | >10 000 | >5 |
P9 worked in four practices; P3 and P21 worked in the same practice.
All PBPs and nurses were independent prescribers.
*Information from National General Practice Profiles41 (lower numbers indicate more deprivation).
†Derived from participant’s depiction of patient population.